首页> 外文期刊>Journal of applied clinical medical physics / >Reproducibility of the external surface position in left‐breast DIBH radiotherapy with spirometer‐based monitoring
【24h】

Reproducibility of the external surface position in left‐breast DIBH radiotherapy with spirometer‐based monitoring

机译:基于肺活量计监测的左乳房DIBH放射治疗中外表面位置的可重复性

获取原文
           

摘要

Deep inspiration breath hold (DIBH) in left-sided breast cancer radiotherapy treatments allows for a reduction in cardiac and pulmonary doses without compromising target coverage. The selection of the most appropriate technology for DIBH monitoring is a crucial issue. We evaluated the stability and reproducibility of DIBHs controlled by a spirometric device, by assessing the variability of the external surface position within a single DIBH (intra-DIBH) and between DIBHs performed in the same treatment session (intrafraction) or in different sessions (interfraction). The study included seven left-breast cancer patients treated with spirometer-based DIBH radiotherapy. Infrared optical tracking was used to record the 3D coordinates of seven to eleven passive markers placed on the patient's thoraco-abdominal surface during 29-43 DIBHs performed in six to eight treatment sessions. The obtained results showed displacements of the external surface between different sessions up to 6.3 mm along a single direction, even at constant inspired volumes. The median value of the interfraction variability in the position of breast passive markers was 2.9 mm (range 1.9-4.8 mm) in the latero-lateral direction, 3.6 mm (range 2.2-4.6 mm) in the antero-posterior direction, and 4.3 mm (range 2.8-6.2 mm) in the cranio-caudal direction. There were no significant dose distribution variations for target and organs at risk with respect to the treatment plan, confirming the adequacy of the applied clinical margins (15 mm) to compensate for the measured setup uncertainties. This study demonstrates that spirometer-based control does not guarantee a stable and reproducible position of the external surface in left-breast DIBH radiotherapy, suggesting the need for more robust DIBH monitoring techniques when reduced margins and setup uncertainties are required for improving normal tissue sparing and decreasing cardiac and pulmonary toxicity.PACS number: 87.55.Km
机译:左侧乳腺癌放射治疗中的深吸气屏息(DIBH)可以减少心脏和肺部的剂量,而不会影响目标的覆盖范围。选择最合适的DIBH监测技术是至关重要的问题。我们通过评估单个DIBH内(DITRAH)内和在同一疗程(Intrafraction)或不同疗程(Interfraction)中进行的DIBH之间的外表面位置的变异性,评估了由肺活量测定仪控制的DIBH的稳定性和可重复性)。该研究包括七名接受基于肺活量计的DIBH放射治疗的左乳腺癌患者。在六到八次治疗中进行的29-43次DIBH期间,使用红外光学跟踪记录了放置在患者胸腹表面上的七到十一个被动标记的3D坐标。所获得的结果表明,即使在恒定吸气量下,外表面之间在单个方向上的位移也高达6.3 mm。乳房被动标志物位置的分数变异性的中值在外侧方向为2.9 mm(范围1.9-4.8 mm),在前后方向为3.6 mm(范围2.2-4.6 mm),并且为4.3 mm (范围2.8-6.2 mm)在颅尾方向。就治疗计划而言,靶标和有风险的器官没有明显的剂量分布变化,证实了所应用的临床余量(15毫米)足以补偿所测量的装置不确定性。这项研究表明,基于肺活量计的控制不能保证左乳房DIBH放射治疗中外表面的位置稳定且可重现,这表明当需要减少切缘和设置不确定性以改善正常组织保留和恢复时,需要更强大的DIBH监测技术降低心脏和肺毒性。PACS数:87.55.Km

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号